Email This Article

Headlines & Perspectives
FDA: More Label Warnings for Anemia Drugs
By Elizabeth Trotta
07/31/08 - 12:46 AM EDT
The regulatory agency issues further label revisions for drugs like Amgen's Aranesp and J&J's Procrit.
Recipient's Email Address(es)
(Separate multiple addresses with a comma)
Your Email Address
Send a copy to myself
Your Message (optional)
Dow Jones S&P 500 NASDAQ 10-Year Note
10,405.83 1,102.35 2,190.86 34.82
Oil *
71.98
UP
68.78
UP
6.41
UP
7.13
UP
0.59
10 Yr
3.48%
SPDR Gold
110.82
+0.67%
+0.58%
+0.33%
+1.72%
Data delayed 20 minutes

Brokerage Partners